Skip to main content
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. — Investor Relations & Filings

Ticker · NDRA ISIN · US29273B1044 LEI · 6488380RAKK4NN716I68 US Manufacturing
Filings indexed 506 across all filing types
Latest filing 2025-05-15 Regulatory Filings
Country US United States of America
Listing US NDRA

About ENDRA Life Sciences Inc.

https://www.endrainc.com/

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. The company's core technology is the Thermo-Acoustic Enhanced UltraSound (TAEUS®) platform, designed to enable clinicians to visualize tissue composition and function. The initial application of TAEUS is focused on the early detection and monitoring of liver disease by quantifying fat in the liver. This addresses the clinical need for assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), which are often difficult to diagnose in their early stages. The TAEUS system aims to provide a safe, non-invasive, and cost-effective diagnostic tool that can be used at the point of patient care, offering an alternative to more expensive and less accessible imaging methods.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings
2025-05-15 English
Regulatory Filings 2025
Regulatory Filings
2025-05-08 English
FORM 10-K
Annual Report FY 2024
2025-04-04 English
FORM S-8
Registration Form
2025-04-02 English
FORM 10-K
Annual Report FY 2024
2025-03-31 English
FORM 8-K
Regulatory Filings
2025-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.